Information Provided By:
Fly News Breaks for August 16, 2017
CVS
Aug 16, 2017 | 14:06 EDT
Wolfe Research analyst Scott Mushkin earlier today downgraded CVS Health to Peer Perform from Outperform. The analyst sees an environment where "stronger growth and profits are increasingly harder to come by." Mushkin this morning also lowered his Drug Retail industry rating to Market Weight from Market Overweight. His 2017 fair value estimate is $82 relative to his previous price target of $89.
News For CVS From the Last 2 Days
There are no results for your query CVS
I agree to the thefly.com's disclaimer & terms of use
About Privacy Terms of Use

© 1996-2018 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.